104P Final analysis of the prospective, randomized phase II STAMP trial: Adjuvant gemcitabine plus cisplatin (GemCis) versus capecitabine (CAP) in node-positive extrahepatic cholangiocarcinoma (CCA)
作者
Hyehyun Jeong,K-P. Kim,Jae Ho Jeong,Dae Wook Hwang,Jeong Hyun Lee,KH Kim,D-B Moon,M.A. Lee,S.J. Park,Hong Jae Chon,Jin‐hong Park,Jong Soo Lee,B-Y. Ryoo,Changhoon Yoo